loader

knight therapeutics inc.

LATEST ARTICLES

Knight Therapeutics Announces Health Canada Approval for WYNZORA® to Treat Psoriasis Vulgaris

Knight Therapeutics Reports Third Quarter 2025 Results

Knight Announces Closing of US$100 Million Revolving Credit Facility

Knight Therapeutics Announces Launch of JORNAY PM in Canada

Knight Therapeutics Announces Approval and Launch of MINJUVI® in Argentina

Notice of Knight Therapeutics' Third Quarter 2025 Results Conference Call

Knight Therapeutics Announces Relaunch of ORGOVYX® in Canada

Knight Therapeutics Announces Relaunch of MYFEMBREE® in Canada

Knight Therapeutics Inc. places No. 384 on The Globe and Mail's seventh annual ranking of Canada's Top Growing Companies

Knight Announces Normal Course Issuer Bid

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES